Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547453 · ClinicalTrials.gov registry record
Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
A clinical trial, sponsored by Cornell University.
- Completed
- Registry status
- 240
- Enrollment target
NCT03547453: Completed study, sponsored by Cornell University.
NCT03547453 is a clinical trial that has completed, run by Cornell University. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03547453 has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
The investigators would like to determine how aspects of adiposity and age influence ultrasound features of the ovaries which are used to diagnose polycystic ovarian syndrome (PCOS). The study will also compare anti-Müllerian hormone (AMH) levels against ultrasound features of the ovary to predict PCOS.
Primary Outcome
The number of follicles in each ovary will be assessed by ultrasonography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2022-12-31 |
What the finished NCT03547453 record still lists
NCT03547453 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03547453 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03547453 about?
NCT03547453 is a clinical study titled "Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome". The investigators would like to determine how aspects of adiposity and age influence ultrasound features of the ovaries which are used to diagnose polycystic ovarian syndrome (PCOS). The study will also compare anti-Müllerian hormone (AMH) levels against ultrasound features of the ovary to predict P...
What is the current status of trial NCT03547453?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2018-06-04. Estimated completion is 2022-12-31.
Who is sponsoring clinical trial NCT03547453?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI